“Statistically-Significant Meta-Analyses of Clinical Trials Have Modest Credibility and Inflated Effects”, Tiago V. Pereira, John Ioannidis2011-10 (, )⁠:

Objective: To assess whether nominally statistically-significant effects in meta-analyses of clinical trials are true and whether their magnitude is inflated.

Study Design & Setting: Data from the Cochrane Database of Systematic Reviews 2005 (issue 4) and 2010 (issue 1) were used. We considered meta-analyses with binary outcomes and 4 or more trials in 2005 with p < 0.05 for the random-effects odds ratio (OR). We examined whether any of these meta-analyses had updated counterparts in 2010. We estimated the credibility (true-positive probability) under different prior assumptions and inflation in OR estimates in 2005.

Results: 461 meta-analyses in 2005 were eligible, and 80 had additional trials included by 2010. The effect sizes (ORs) were smaller in the updating data (20055201014ya) than in the respective meta-analyses in 2005 (median 0.85×, interquartile range [IQR]: 0.66–1.06), even more prominently for meta-analyses with less than 300 events in 2005 (median 0.67×, IQR: 0.54–0.96). Mean credibility of the 461 meta-analyses in 2005 was 63–84% depending on the assumptions made. Credibility estimates changed >20% in 19–31 (24–39%) of the 80 updated meta-analyses.

Conclusion: Most meta-analyses with nominally statistically-significant results pertain to truly non-null effects, but exceptions are not uncommon. The magnitude of observed effects, especially in meta-analyses with limited evidence, is often inflated.

[Keywords: meta-analysis, bias, treatment effect, Bayes factor, winner’s curse, outcomes]